For the year ending 2025-12-31, NAMSW has $769,284K in assets. $85,853K in debts. $490,002K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 490,002 | |||
| Prepayments and other receivables | 38,138 | |||
| Marketable securities, current | 146,239 | |||
| Restricted cash | 1,321 | |||
| Total current assets | 675,700 | |||
| Marketable securities, net of current portion | 92,609 | |||
| Property, plant and equipment, net | 383 | |||
| Operating right of use asset | 185 | |||
| Intangible assets | 407 | |||
| Total assets | 769,284 | |||
| Accounts payable | 8,970 | |||
| Accrued expenses and other current liabilities | 15,422 | |||
| Deferred revenue, current | 3,987 | |||
| Lease liability, current | 136 | |||
| Derivative warrant liabilities | 57,272 | |||
| Total current liabilities | 85,787 | |||
| Lease liability, net of current portion | 66 | |||
| Total liabilities | 85,853 | |||
| Ordinary shares | 14,278 | |||
| Additional paid-in capital | 1,426,750 | |||
| Accumulated loss | -762,390 | |||
| Accumulated other comprehensive income | 4,793 | |||
| Total shareholders' equity | 683,431 | |||
| Total liabilities and shareholders' equity | 769,284 | |||
NewAmsterdam Pharma Co N.V. (NAMSW)
NewAmsterdam Pharma Co N.V. (NAMSW)